BACKGROUND: Lipoprotein(a) [Lp(a)] level is a novel risk factor for atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia (FH), while its impact on the different sites of arteries remains undetermined. We aim to examine the associations of Lp(a) levels with coronary and carotid atherosclerosis in patients with heterozygous FH (HeFH). METHODS: A total of 148 patients with HeFH who have received carotid ultrasonography and coronary angiography due to chest pain were enrolled. Plasma Lp(a) was measured using immunoturbidimetric method. Finally, the associations between Lp(a) and coronary as well as carotid lesions were evaluated. RESULTS: Patients with Lp(a) ≥ 300 mg/L had similar carotid intima-media thickness (IMT, 0.782 ± 0.16 mm vs 0.798 ± 0.18 mm, P = .579) and plaque prevalence (66.7% vs 65%, P = .833) compared to those with Lp(a) < 300 mg/L, but had a higher prevalence of coronary artery disease (CAD, 69.7% vs 50.0%, P = .016) and higher Gensini score (GS, median 27 vs 3, P = .006). Moreover, no correlations were found between carotid mean IMT with either Lp(a) level or Lp(a) year score, while positive relation of Lp(a) with GS did. Multivariate regression analysis revealed that Lp(a), Lp(a) year score, and Lp(a) ≥ 300 g/L were all independent predictors for the presence of CAD (OR = 4.99, P = .007; OR = 4.73, P = .009; OR = 4.46, P = .006, respectively) but not for carotid plaques. CONCLUSIONS: This study suggested that Lp(a) level was associated with the presence and severity of CAD but not with carotid atherosclerosis in patients with HeFH.
BACKGROUND:Lipoprotein(a) [Lp(a)] level is a novel risk factor for atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia (FH), while its impact on the different sites of arteries remains undetermined. We aim to examine the associations of Lp(a) levels with coronary and carotid atherosclerosis in patients with heterozygous FH (HeFH). METHODS: A total of 148 patients with HeFH who have received carotid ultrasonography and coronary angiography due to chest pain were enrolled. Plasma Lp(a) was measured using immunoturbidimetric method. Finally, the associations between Lp(a) and coronary as well as carotid lesions were evaluated. RESULTS:Patients with Lp(a) ≥ 300 mg/L had similar carotid intima-media thickness (IMT, 0.782 ± 0.16 mm vs 0.798 ± 0.18 mm, P = .579) and plaque prevalence (66.7% vs 65%, P = .833) compared to those with Lp(a) < 300 mg/L, but had a higher prevalence of coronary artery disease (CAD, 69.7% vs 50.0%, P = .016) and higher Gensini score (GS, median 27 vs 3, P = .006). Moreover, no correlations were found between carotid mean IMT with either Lp(a) level or Lp(a) year score, while positive relation of Lp(a) with GS did. Multivariate regression analysis revealed that Lp(a), Lp(a) year score, and Lp(a) ≥ 300 g/L were all independent predictors for the presence of CAD (OR = 4.99, P = .007; OR = 4.73, P = .009; OR = 4.46, P = .006, respectively) but not for carotid plaques. CONCLUSIONS: This study suggested that Lp(a) level was associated with the presence and severity of CAD but not with carotid atherosclerosis in patients with HeFH.
Authors: Rodrigo Alonso; Eduardo Andres; Nelva Mata; Francisco Fuentes-Jiménez; Lina Badimón; José López-Miranda; Teresa Padró; Ovidio Muñiz; Jose Luis Díaz-Díaz; Marta Mauri; Jose María Ordovás; Pedro Mata Journal: J Am Coll Cardiol Date: 2014-03-13 Impact factor: 24.094
Authors: Alexander H Nave; Kristin S Lange; Christopher O Leonards; Bob Siegerink; Wolfram Doehner; Ulf Landmesser; Elisabeth Steinhagen-Thiessen; Matthias Endres; Martin Ebinger Journal: Atherosclerosis Date: 2015-08-15 Impact factor: 5.162
Authors: Sven Bos; Martijne H C Duvekot; Gert-Jan R Ten Kate; Adrie J M Verhoeven; Monique T Mulder; Arend F L Schinkel; Koen Nieman; Gerald F Watts; Eric J G Sijbrands; Jeanine E Roeters van Lennep Journal: Atherosclerosis Date: 2016-12-02 Impact factor: 5.162
Authors: Sebhat Erqou; Stephen Kaptoge; Philip L Perry; Emanuele Di Angelantonio; Alexander Thompson; Ian R White; Santica M Marcovina; Rory Collins; Simon G Thompson; John Danesh Journal: JAMA Date: 2009-07-22 Impact factor: 56.272
Authors: Michelle L O'Donoghue; David A Morrow; Sotirios Tsimikas; Sarah Sloan; Angela F Ren; Elaine B Hoffman; Nihar R Desai; Scott D Solomon; Michael Domanski; Kiyohito Arai; Stephanie E Chiuve; Christopher P Cannon; Frank M Sacks; Marc S Sabatine Journal: J Am Coll Cardiol Date: 2013-10-23 Impact factor: 24.094
Authors: Brian T Steffen; George Thanassoulis; Daniel Duprez; James H Stein; Amy B Karger; Mathew C Tattersall; Joel D Kaufman; Weihua Guan; Michael Y Tsai Journal: Arterioscler Thromb Vasc Biol Date: 2019-03 Impact factor: 8.311